MedTrace Logo

Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)

NCT00464698 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-03-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the efficacy of Duloxetine in the treatment of obsessive compulsive disorder.

Conditions

  • Obsessive Compulsive Disorder

Interventions

DRUG

Duloxetine

Participants received increasing amounts of Duloxetine for 7 weeks.

Sponsors & Collaborators

Principal Investigators

  • Darin D Dougherty, MD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00464698 on ClinicalTrials.gov